ASTRA TECH Implant System, OsseoSpeed™
DeviceASTRA TECH Implant System, OsseoSpeed™: Ø 3.5, 4, 4.5, 5.0 mm in lengths of 8, 9, 11, 13, 15, 17 and 19 mm.
NCT Number: NCT00710944
The purpose of this study is to evaluate survival for ASTRA TECH Implant System, OsseoSpeed™ implants following immediate loading in extraction sockets versus immediate loading in healed ridges. Patients in need of single standing implants replacing teeth in the maxilla within zone 15-25 will be included and followed for 5 years. Primary objective is implant survival rate at 12 months.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Dental School Department Periodontology, Ghent, Belgium
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
ASTRA TECH Implant System, OsseoSpeed™: Ø 3.5, 4, 4.5, 5.0 mm in lengths of 8, 9, 11, 13, 15, 17 and 19 mm.
Time frame: 12 months after implant placement
An implant that has failed to osseointegrate, lost its osseointegration or fractured was considered a failure effective from the date of removal. The survival rate for individual implants was analyzed at each visit. Cumulative implant survival rate was calculated using Kaplan-Meier life-table estimation and reported as percentage of survived implants.
Dentsply Sirona Implants and Consumables
Industry
An Open, Prospective, Controlled Study in the Maxilla to Evaluate Clinical Outcome of ASTRA TECH Implant System, OsseoSpeed™ Implants in Single Tooth Replacement Using an Immediate Loading Protocol in Extraction Sockets and Healed Ridges.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00711113
Jaw Diseases, Jaw, Edentulous
Iowa City, Iowa, United States
View Trial DetailsNCT00711425
Jaw Diseases, Jaw, Edentulous
Columbus, Ohio, United States
View Trial DetailsNCT07456995
Dental Implant, Jaw Diseases
Giza, Giza Governorate, Egypt
View Trial DetailsNCT06580483
Jaw Diseases, Jaw, Edentulous
Al Mansurah, Egypt
View Trial Details